All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 128 of 206 pages ‹ First < 126 127 128 129 130 > Last ›
HSL1583
Kowalczyk L.
Psychiatry funding questioned: Drug firms aid Mass. General
The Boston Globe 2005 May 14;
HSL1553
Common drugs raise heart threat
BBC News 2005 May 11;
http://news.bbc.co.uk/go/pr/fr/-/1/hi/health/4535697.stm
HSL1555
Silverman E.
Biz Buzz: Actress's on-screen personalities collide at conference
New Jersey Star Ledger 2005 May 11;
HSL1509
Stafford A, Allen L.
Drug companies, doctors face curbs
The Financial Review 2005 May 10;
HSL1511
Allen L.
Fee rise will hit vitamins, medicines
The Financial Review 2005 May 10;
HSL1512
Reuters .
Drug Makers Set Out to Create Ad Guidelines to Improve Image
REUTERS NEWS SERVICE 2005 May 10;
HSL1572
Kaisernetwork.org
Prescription Drugs: PhRMA CEO Tauzin Discusses Drug Industry Image, Reimportation, Other Issues
kaisernetwork.org 2005 May 10;
HSL1576
Dabade G.
Of patents, licences and drug prices
Deccan Herald 2005 May 10;
HSL1510
Frenkel J, Harvey M, McManus G.
$800m boost for cheaper medicine
The Herald Sun 2005 May 9;
HSL1554
Pollack A.
Marketing a Disease, and Also a Drug to Treat It
The New York Times 2005 May 9;
HSL1571
Edelman S.
CONTRA-DECEPTION
The New York Post 2005 May 9;
HSL1584
Connolly C.
Pentagon to Drop Nexium From Its List Of Covered Drugs for Military Personnel 'Purple Pill' Nexium the First to Be Cut
The Washington Post 2005 May 8;
HSL3779
Cohen AF.
[The pharmaceutical industry in uproar]
Ned Tijdschr Geneeskd 2005 May 7;149:(19):1074
HSL1503
Kaufman M.
Merck CEO Resigns as Drug Probe Continues
The Washington Post 2005 May 6;
HSL1504
Appleby J.
Merck's marketing of Vioxx called misleading
USA TODAY 2005 May 6;
http://www.usatoday.com/printedition/money/20050506/vioxx06.art.htm
HSL1505
Krugman P.
A Serious Drug Problem
The New York Times 2005 May 6;
HSL1508
Reuters .
Regulator slaps Pfizer on Zoloft ads: FDA orders No. 1 drugmaker to halt ads neglecting to warn of antidepressant's fatal side effects.
CNN Money 2005 May 6;
HSL1561
Gottlieb S.
Big Pharma's New Funk
Forbes.com 2005 May 6;
HSL1575
Blumenstyk G.
Universities Fear a California Ruling Could Set a Precedent, Leaving Them Liable for Research Sponsors' Lost Profits
Chronicle of Higher Education 2005 May 6;
HSL19788
Cole L
Medical sponsorship thrown under further scrutiny
Medical Observer 2005 May 6
HSL1506
Waxman HA
Merck Documents Show Aggressive Marketing of Vioxx After Studies Indicated Risk
: United States House of Representatives Commitee on Government Reform Minority Office 2005 May 5
http://www.democrats.reform.house.gov/story.asp?ID=848
HSL1500
Solomon J.
Researchers Tested AIDS Drugs on Children
LA Times 2005 May 4;
HSL1501
Kaufman M.
Clinical Trials of Drugs Fewer, Study Says: Report Also Notes Decline in Number of Principal Investigators in U.S.
The Washington Post 2005 May 4;
HSL1507
Harris G.
Petition Seeks Warning on Anticancer Medication
The New York Times 2005 May 4;
HSL1590
Solomon J.
Government tested AIDS drugs on foster kids: Children not provided with basic legal protection, review finds
The Associated Press 2005 May 4;
HSL1498
Dinant G-J, Mansfield P.
Van zoete koek naar gezonde scepsis: De houding van huisartsen tegenover geneesmiddelenreclame
Huisarts Wet 2005 May 2;48:(6):304-307
http://vb23.bsl.nl/frontend/framesets/index_henw.asp?custom_product_id=0018-7070&product_id=
HSL1061
Scherer M.
The Side Effects of Truth: In exposing the deadly threat posed by Vioxx, FDA researcher David Graham was serving the public interest. His bosses had other interests in mind.
Mother Jones 2005 May 1
HSL1296
Cutting Edge
Oncology Brand Commercialization: Resource Allocation
2005 May
http://www.pharmaoncologymarketing.com/
HSL1559
Tansey B.
Why doctors prescribe off label
San Francisco Chronicle 2005 May 1;
HSL3712
Diller L.
Fallout from the pharma scandals: the loss of doctors' credibility?
Hastings Cent Rep 2005 May-Jun 01;35:(3):28-9
HSL3740
Tonkens R.
An overview of the drug development process.
Physician Exec 2005 May-Jun 01;31:(3):48-52
HSL3755
Hamrin V, Scahill L.
Selective serotonin reuptake inhibitors for children and adolescents with major depression: current controversies and recommendations.
Issues Ment Health Nurs 2005 May 01;26:(4):433-50
HSL3768
Allen TS Jr, Henderson JH Jr.
Merck VIOXX "warning" is questioned.
Tex Med 2005 May 01;101:(5):5-6
HSL3774
Thacker PD.
Pharmaceutical data elude researchers.
Environ Sci Technol 2005 May 1;39:(9):193A-194A
HSL3783
Ahlborn H, Henderson S, Davies N.
No immediate pain relief for the pharmaceutical industry.
Curr Opin Drug Discov Devel 2005 May 01;8:(3):384-91
HSL3784
Torr-Brown S.
Advances in knowledge management for pharmaceutical research and development.
Curr Opin Drug Discov Devel 2005 May 01;8:(3):316-22
HSL3785
Gund P, Maliski E, Brown F.
Editorial overview: whither the pharmaceutical industry?
Curr Opin Drug Discov Devel 2005 May 01;8:(3):296-7
HSL3786
Longstaff C, Thelwell C, Whitton C.
The poor quality of streptokinase products in use in developing countries.
J Thromb Haemost 2005 May 01;3:(5):1092-3
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3046&uid=15869616&db=pubmed&url=http://dx.doi.org/10.1111/j.1538-7836.2005.01271.x
HSL3788
MacDonald A.
Ethics committee approval of multicentre studies.
Intern Med J 2005 May 01;35:(5):311-2
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1445-5994.2005.00827.x
HSL3805
Ashcroft DM, Quinlan P, Blenkinsopp A.
Prospective study of the incidence, nature and causes of dispensing errors in community pharmacies.
Pharmacoepidemiol Drug Saf 2005 May 01;14:(5):327-32
http://www3.interscience.wiley.com/cgi-bin/abstract/109608242/ABSTRACT
HSL4807
Shah RV, Albert TJ, Bruegel-Sanchez V, Vaccaro AR, Hilibrand AS, Grauer JN.
Industry support and correlation to study outcome for papers published in Spine.
Spine 2005 May 1;30:(9):1099-104
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0362-2436&volume=30&issue=9&spage=1099
HSL4947
Dallegri F, Bertolotto M, Ottonello L.
A review of the emerging profile of the anti-inflammatory drug oxaprozin.
Expert Opin Pharmacother 2005 May 01;6:(5):777-85
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3204&uid=15934904&db=PubMed&url=http://www.ashley-pub.com/doi/abs/10.1517/14656566.6.5.777
HSL4948
Silay YS, Jankovic J.
Emerging drugs in Tourette syndrome.
Expert Opin Emerg Drugs 2005 May 01;10:(2):365-80
http://www.expertopin.com/doi/abs/10.1517/14728214.10.2.365
HSL4950
Austin S.
Drug Discovery Technology Europe 2005 - IBC's Ninth Annual Conference and Exhibition.
IDrugs 2005 May 01;8:(5):370-3
HSL4951
Ulmer JB.
DNA vaccines forum: how to enhance DNA vaccines safety and potency?
IDrugs 2005 May 01;8:(5):357-9
HSL1636
Offit PA.
Why are pharmaceutical companies gradually abandoning vaccines?
Health Aff (Millwood) 2005 May-Jun;24:(3):622-30
http://content.healthaffairs.org/cgi/content/full/24/3/622
HSL2110
McMullin ST, Lonergan TP, Rynearson CS.
Twelve-month drug cost savings related to use of an electronic prescribing system with integrated decision support in primary care.
J Manag Care Pharm 2005 May;11:(4):322-32
HSL2119
Doucette WR, Andersen TN.
Practitioner activities in patient education and drug therapy monitoring for community dwelling elderly patients.
Patient Educ Couns 2005 May;57:(2):204-10
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6TBC-4CTN99X-1&_coverDate=05%2F31%2F2005&_alid=305102447&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=5139&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=e37975b79e203a300424ac0c151ffb6b
HSL2120
Mebane FE.
The importance of news media in pharmaceutical risk communication: proceedings of a workshop.
Pharmacoepidemiol Drug Saf 2005 May;14:(5):297-306
http://www3.interscience.wiley.com/cgi-bin/abstract/109596257/ABSTRACT
HSL4859
Sociedades Medicas-Cientificas miembros de la Asociacion de Sociedades Cientificas-Medicas de Chile.
[Recommendations to avoid conflicts of interest].
Rev Med Chil 2005 May;133:(5):607-8
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005000500015&lng=en&nrm=iso
HSL4949
Haurum J, Bregenholt S.
Recombinant polyclonal antibodies: therapeutic antibody technologies come full circle.
IDrugs 2005 May;8:(5):404-9
HSL8797
Committee on Publication Ethics (COPE).
[Guidelines on good publication practice: the committe on publication ethics (COPE) report 2003].
Pro Fono 2005 May-Aug;17:(2):264-70
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16909537&query_hl=8&itool=pubmed_DocSum
HSL11295
Pentecost MJ.
Vioxx, radiology, and the Food and Drug Administration.
J Am Coll Radiol 2005 May;2:(5):394-7
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17411841&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL1502
Morgan D, Kaufman M.
FDA Calls Efforts For Bayer Illegal: Lawmakers' Help for Drug Firm Tests Limits
The Washington Post 2005 Apr 30;
HSL19749
Parnell K
Sex drives drug sales and patient discussion
Australian Doctor 2005 Apr 29
www.australiandoctor.com.au
HSL1514
Ismail A.
Prescription for Power: Drug makers' lobbying army ensures their legislative dominance
The Center for Public Integrity 2005 Apr 28;
HSL1062
Hirsch M.
UCSF med students say no to drug reps
The San Francisco Bay Guardian 2005-2005 Apr-May 27-3
http://www.sfbg.com/39/30/news_ucsf.html
HSL1689
Kravitz RL, Epstein RM, Feldman MD, Franz CE, Azari R, Wilkes MS, Hinton L, Franks P.
Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial.
JAMA 2005 Apr 27;293:(16):1995-2002
http://jama.ama-assn.org/cgi/content/full/293/16/1995
HSL14686
Procopio M.
The multiple outcomes bias in antidepressants research
Medical Hypotheses 2005 Apr 27;65:(2):395-399
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WN2-4G1V67S-3&_user=10&_coverDate=12%2F31%2F2005&_rdoc=34&_fmt=high&_orig=browse&_srch=doc-info(%23toc%236950%232005%23999349997%23596828%23FLA%23display%23Volume)&_cdi=6950&_sort=d&_docanchor=&_ct=44&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=37fe41b4681d8d3bc5e4b145a9cd6e12
HSL1063
Vedantam S, Kaufman M.
Doctors Influenced By Mention Of Drug Ads
The Washington Post 2005 Apr 26
HSL1562
Friedman R.
Mix Math and Medicine and Create Confusion
The New York Times 2005 Apr 26;
HSL1595
Pringle E.
Bush-Backed Drug Marketing Schemes
The Sierra Time 2005 Apr 26;
HSL17388
DeNoon DJ
Study: Patients Who Ask Doc for Drugs Get Them
FOX News 2005 Apr 26
http://www.foxnews.com/story/0,2933,154697,00.html
HSL973
Barrett A, Carey J.
"Off-Label" Drugs: J&J Is Pushing The Envelope.
Business Week 2005 Apr 25
http://www.businessweek.com/magazine/content/05_17/b3930071_mz011.htm
HSL1513
Drinkard J.
Drugmakers go furthest to sway Congress
USA TODAY 2005 Apr 25
HSL1574
Berenson A.
Evidence in Vioxx Suits Shows Intervention by Merck Officials
The New York Times 2005 Apr 24;
HSL1090
Women and Health Protection researcher a finalist in Canadian Geographic Environment Awards
Women and Health Protection and the Canadian Women's Health Network 2005 Apr 23
HSL1573
Vesely R.
Medical group OKs ethics rules
San Gabriel Valley Tribune 2005 Apr 23;
HSL19953
Limprecht E
Warning to drug companies: cross the TGA and risk a fine
Australian Doctor 2005 Apr 22
http://www.australiandoctor.com.au/news/warning-to-drug-companies--cross-the-tga-and-risk-
HSL20083
Limprecht E
Critic prompts review of pharma ads
Australian Doctor 2005 Apr 226
http://www.australiandoctor.com.au/news/latest-news/critic-prompts-review-of-pharma-ads
HSL975
Boseley S.
US accused of trying to block abortion pills
The Guardian 2005 Apr 21
HSL977
Vasil A.
Smart Regs really dumb: "Efficiency" scheme on eco and health regs threaten our own protections
Toronto's 'NOW' Magazine 2005-2005 Apr-Apr 21-27
HSL971
Kowalczyk L.
FDA requests anticonvulsants be reexamined
The Boston Globe 2005 Apr 20
HSL974
Risk of death is linked with Natrecor
Newz.in 2005 Apr 20
HSL972
Drug May Raise Risk of Dying, Research Says
The Washignton Post 2005 Apr 19
HSL978
Brown D.
Establishing Proof: Some Fifty Years Ago a Baby-Blinding Epidemic Confounded Experts -- Until a Pioneering Study Conclusively Tied Cause and Effect, and Enshrined Clinical Trials in Medical Practice
The Washington Post 2005 Apr 19
HSL980
Kornblut A, Wilson D.
Beyond Balco: How One Pill Escaped the List of Controlled Steroids
The New York Times 2005 Apr 17
HSL981
Greve F.
Statistics on disease prevalence often inflated
Kansas City Star 2005 Apr 17
HSL968
Pollard R.
Lax system means killer drugs slip through
Sydney Morning Herald 2005 Apr 16
HSL965
Sullivan J.
Official fined for ethics breach: The state's top pharmacist plans to appeal a ruling that a pharmaceutical firm gave him cash and trips.
Philadelphia Inquirer 2005 Apr 15
HSL966
Moran M.
Zyprexa IM Caution Issued in Some Countries But Not U.S.
Psychiatric News 2005 Apr 15
HSL967
Jacklet B.
Drug firm makes editor's job a pain: A medical journal's article rejection sets off industrywide brouhaha
The Portland Tribune 2005 Apr 15
HSL984
Wilde-mathews A, Schaefer-muÑoz S.
Judge Overturns Ban on Ephedra, Roils FDA Policy
The Wall Street Journal 2005 Apr 15
HSL5323
Comments of Consumers Union before the Food and Drug Administration Science Board
: Food and Drug Administration 2005 Apr 15
http://www.fda.gov/ohrms/dockets/ac/05/slides/2005-4136OPH_02_01_Consumer's%20Union.pdf
HSL19826
Suanders C
Drug companies fined $100,000 over confusing packs
Australian Doctor 2005 Apr 15
http://www.australiandoctor.com.au
HSL20084
Taylor R
I hate adverts
Australian Doctor 2005 Apr 1531
HSL20085
Montgomery B, Mansfield PR
Thiazide, please
Australian Doctor 2005 Apr 1531
HSL970
BBC News.
GSK investors bring Paxil lawsuit
BBC News 2005 Apr 14
HSL982
Alonso-zaldivar R.
A Silicone Implant Gets Panel's OK
The LA Times 2005 Apr 14
HSL983
Pringle E
TeenScreen - Angel of Mercy or Pill-Pusher
www.OpEdNews.com 2005 Apr 14
HSL1557
Seminário Internacional discute a propaganda de medicamentos
2005 Apr 14
http://www.opas.org.br/medicamentos/index.cfm?ent=2&carregar=2&action=mostrar&codigo=136
HSL957
Mathews AW.
FDA Panel Backs Implant Restrictions
The Wall Street Journal 2005 Apr 13
HSL961
Santora M, Carey B.
Depressed? New York City Screens for People at Risk
The New York Times 2005 Apr 13
HSL1089
Hankin Joan.
Levitra® (vardenafil HCl) Tablets
FDA 2005 Apr 13
http://web.archive.org/web/20090118215108/http://www.fda.gov/cder/warn/2005/Levitra.pdf
HSL946
Stafford A, Davis M.
Threat to PBS and Medicare safety nets
The Financial Review 2005 Apr 12
HSL950
Schneemann K.
Health spending justified
The Australian 2005 Apr 12
HSL959
White M.
Tighter controls promised on drug claims: Pharmaceutical companies to be forced to publish details of side-effects
The Guardian 2005 Apr 12
HSL962
Carey E.
Cholesterol drug spending may soar: Guidelines say 27% more patients need statins But few benefits for low-risk patients, study says
The Toronto Star 2005 Apr 12
HSL963
Harris G.
Popular Drugs for Dementia Tied to Deaths
The New York Times 2005 Apr 12
HSL3791
Hoffer LJ, Mendelson J.
Clinical trials registry.
CMAJ 2005 Apr 12;172:(8):980
Page 128 of 206 pages ‹ First < 126 127 128 129 130 > Last ›
